Recombinant Human AKR1B1

Este producto es parte de AKR1B - Aldo-keto reductase family 1 member B
Product Graph
Contáctenos para saber el precio

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Recombinant Human AKR1B1
category
Proteins and Peptides
provider
FineTest
reference
P8101
tested applications
Western Blot, ELISA

Documents del producto

Instrucciones
Descargar
Data sheet

Product specifications

CategoryProteins and Peptides
Immunogen Target1-316
HostE.Coli
OriginHuman
Observed MW37.7 kDa
ExpressionRecombinant
PurityGreater than 95% by SDS-PAGE gel analyses
PurificationN-terminal His Tag
Size 150μg
Size 2200μg
Size 31mg
FormLyophilized from a 0.2um filtered solution in PBS with 5% trehalose and 0.06% proclin, pH7.4
Tested ApplicationsWestern Blot, ELISA
BufferCentrifuge the vial at 10,000 rpm for 1 minute, reconstitute at 200 μg/ml in Reconstitute with Sterile distilled water
Availability3-4 weeks
Storage-20°C for 12 months as lyophilized;2-8°C for 1 month under sterile conditions after reconstitution
UniProt IDP15121
AliasAKR1B1,ADR ALDR1,ALR2,AR
BackgroundProteins AKR1B1
StatusRUO
NoteThis product is for research use only.

AKR1B1, also known as aldose reductase, is a key enzyme in the polyol pathway that converts glucose to sorbitol under hyperglycemic conditions. It has a significant role in the pathogenesis of diabetic complications, such as neuropathy, nephropathy, and retinopathy, as sorbitol accumulation induces osmotic stress and oxidative damage. AKR1B1 also metabolizes reactive aldehydes, including lipid peroxidation products like 4-hydroxynonenal (4-HNE), contributing to cellular detoxification under oxidative stress. Its overactivation under diabetic and inflammatory conditions exacerbates oxidative stress and inflammatory signaling pathways. AKR1B1 inhibitors have been developed as potential therapeutic agents for managing diabetic complications. Beyond diabetes, AKR1B1 is involved in steroid metabolism and the detoxification of xenobiotics. It has also been implicated in cancer progression, as its expression is upregulated in some tumors, promoting proliferation and chemoresistance by reducing reactive aldehydes and maintaining cellular redox balance.

Related Products

EH2164

Human AKR1B1(Aldose reductase) ELISA Kit

Ver Producto
EM0742

Mouse Akr1b1(Aldose reductase) ELISA Kit

Ver Producto
ER1597

Rat AKR1B1(Aldose reductase) ELISA Kit

Ver Producto